authors
- Gill, Sharlene
- Ko, Yoo-Joung
- Cripps, M Christine
- Beaudoin, Annie
- Dhesy-Thind, Sukhbinder
- Zulfiqar, Muhammad
- Zalewski, Pawel
- Do, Thuan
- Cano, Pablo Oscar
- Lam, Wendy
- Dowden, Scot D
- Grassin, Helene
- Stewart, John
- Moore, Malcolm J
PANCREOX: A randomized phase 3 study of 5FU/LV with or without oxaliplatin for second-line advanced pancreatic cancer (APC) in patients (pts) who have received gemcitabine (GEM)based chemotherapy (CT).
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- May 20, 2014
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal